PharmaRoth Labs (PharmaRoth Labs) Change In Payables And Accrued Expense : $0.06 Mil (TTM As of Mar. 2011)

View and export this data going back to 2008. Start your Free Trial

What is PharmaRoth Labs Change In Payables And Accrued Expense?

PharmaRoth Labs's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2011 was $0.05 Mil. It means PharmaRoth Labs's Accounts Payable & Accrued Expense increased by $0.05 Mil from Dec. 2010 to Mar. 2011 .

PharmaRoth Labs's Change In Payables And Accrued Expense for the fiscal year that ended in Jun. 2010 was $-0.00 Mil. It means PharmaRoth Labs's Accounts Payable & Accrued Expense declined by $0.00 Mil from Jun. 2009 to Jun. 2010 .

PharmaRoth Labs Change In Payables And Accrued Expense Historical Data

The historical data trend for PharmaRoth Labs's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaRoth Labs Change In Payables And Accrued Expense Chart

PharmaRoth Labs Annual Data

Trend

Jun08

Jun09

Jun10

Change In Payables And Accrued Expense

0.01

PharmaRoth Labs Quarterly Data
	Mar07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Change In Payables And Accrued Expense	Get a 7-Day Free Trial											-	-0.02	0.01	0.02	0.05

PharmaRoth Labs Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06 Mil.

PharmaRoth Labs Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of PharmaRoth Labs's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaRoth Labs (PharmaRoth Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaRoth Labs Inc (GREY:ROTH) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

8250 West Charleston Boulevard, Suite 110, Las Vegas, NV, USA, 89117

Website

http://www.pharmaroth.com

PharmaRoth Labs Inc is engaged in the manufacture and sale of a treatment for Type II diabetes called Sucanon. The company also does marketing and selling of nutraceutical drugs.

PharmaRoth Labs (PharmaRoth Labs) Headlines

From GuruFocus

Hotchkis and Wiley Value Opportunities Fund Buys Rothschild SCA, Oracle Corp, Medtronic PLC, Sells Amerco Inc, Anthem Inc, F5 Inc

By GuruFocusNews insider • 03-29-2022